By Mary Kekatos Senior Health Reporter For Dailymail.com
Published: 15:49 BST, 22 September 2020 | Updated: 15:54 BST, 22 September 2020
A Centers for Disease Control and Prevention (CDC) committee is delaying a vote on who should get the coronavirus vaccine first in a nationwide rollout.
The Advisory Committee on Immunization Practices (ACIP), which develops guidelines for vaccine administration as well as schedules, was expected to vote virtually on Tuesday.
A plan would be drafted on which groups would be allocated the initial doses of the initial shot - or shots - that are proven safe and effective.
However, members say they want to wait and learn more about which inoculations have the best chance of being approved, The Wall Street Journal reported.
The Advisory Committee on Immunization Practices was expected to vote on who gets initial coronavirus vaccine doses on Tuesday. Pictured: Volunteers are given the Moderna COVID-19 vaccine in Detroit, Michigan, October 5
There are more than 170 coronavirus vaccine candidates in various stages of development around the globe, according to the World Health Organization.
At least nine are currently in large-scale trials in humans to prove the jabs are both safe and effective.
Two-US based companies, Moderna Inc and Pfizer Inc, are in late-stage trials and say they expect